RLMD Intrinsic Valuation and Fundamental Analysis - Relmada Therapeutics Inc

	Relmada Therapeutics Inc NASDAQ:RLMD	US
G	Green Plains Inc XMUN:G3V	US
	Helios Technologies Inc NYSE:HLIO	US

Intrinsic Value

The intrinsic value for Relmada Therapeutics Inc (RLMD) under the Base Case is 3.56 USD. Compared with the current market price of 5.35 USD, the stock appears Overvalued by 34% .

Intrinsic value calculated using DCF

$3.56

Other reference points

Multiples estimate

$0.35

Wall St target

$13.67

Do our valuations actually work? See backtest results .

RLMD Intrinsic Value

Overvaluation 34%

Intrinsic Value

Price $5.35

Track Buy Zone

20% below Intrinsic Value $2.85

Get notified when the price drops into your buy zone

Current Price $5.35

Intrinsic Value $3.56

Margin of Safety 20% $2.85

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Relmada Therapeutics Inc.

Explain Valuation